BBC ETF
Virtus LifeSci Biotech Clinical Trials ETF
BBC ETF Overview
BBC ETF (Virtus LifeSci Biotech Clinical Trials ETF) is managed by Virtus Investment Partners with $50.3M in net assets. BBC expense ratio is 0.65%, holding 132 positions across sectors including Health Care, Industrials. Inception date: 2014-12-16.
BBC performance shows a YTD return of 26.24%. The 1-year return is 129.40% and the 5-year return is 2.60%. BBC dividend yield stands at 1.24%, paid annually.
BBC top holdings include First Tracks Biotherapeutics, Inc. (1.5%), Amylyx Pharmaceuticals Inc (1.4%), Abcellera Biologics Inc. Common Shares (1.4%), Xencor Inc (1.3%), Monopar Therapeutics Inc (1.2%). Go to all BBC holdings, BBC sectors, or BBC dividends.
BBC can be compared against other funds. Use BBC overlap to find shared positions, or BBC vs another fund for a side-by-side view. BBC alternatives are available via the screener, along with tax-loss harvesting opportunities.